Search results
Showing results for
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.
Alex Gordon-Weeks
MBChB, BSc, DPhil, FRCS Alex Gordon-Weeks - Consultant Hepatobiliary Surgeon and Clinical Lecturer
Freddie Hamdy CBE
MBChB, LRCP-LRCSEd, LRCPSGlasg, FRCSEd, FRCSEng, MD (Shef), MA (Oxon) FRCSEd (Urol), FMedSci Freddie Hamdy CBE - Head of Department
Trevor Yeung
MA (Cantab), MBBChir, MRCS, DPhil Trevor Yeung - Clinical Lecturer
Regent Lee
MBBS, MS(Vasc Surg), DPhil (Oxon), FRCS (Vasc Surg) Regent Lee - Professor of Interdisciplinary Innovations
Martin Gillies
MA, BM BCh, PhD, MRCS, AFHEA Martin Gillies - Senior Research Fellow and Lecturer